» Articles » PMID: 26552506

Cardiovascular Risk Assessment and Management in Prerenal Transplantation Candidates

Overview
Journal Am J Cardiol
Date 2015 Nov 11
PMID 26552506
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Cardiovascular (CV) assessment in prerenal transplant patients varies by center. Current guidelines recommend stress testing for candidates if ≥ 3 CV risk factors exist. We evaluated the CV assessment and management in 685 patients referred for kidney transplant over a 7-year period. All patients had CV risk factors, and the most common cause of end-stage renal disease was diabetes. Thirty-three percent (n = 229) underwent coronary angiography. The sensitivity of stress testing to detect obstructive coronary artery disease (CAD) was poor (0.26). Patients who had no CAD, nonobstructive CAD, or CAD with intervention had significantly higher event-free survival compared with patients with obstructive CAD without intervention. There were no adverse clinical events (death, myocardial infarction, stroke, revascularization, and graft failure) within 30 days post-transplant in patients who had preoperative angiography (n = 77). Of the transplanted patients who did not have an angiogram (n = 289), there were 8 clinical events (6 myocardial infarctions) in the first 30 days. In conclusion, our results indicate that stress testing and usual risk factors were poor predictors of obstructive CAD and that revascularization may prove beneficial in these patients.

Citing Articles

Myocardial Perfusion Scintigraphy Provides Incremental Prognostic Value in Patients on the Kidney Transplant Waiting List.

Reuter S, Reiermann S, Stypmann J, Bautz J, Schutte-Nutgen K, Pavenstadt H Clin Transplant. 2025; 39(2):e70114.

PMID: 39980435 PMC: 11843186. DOI: 10.1111/ctr.70114.


External Validation of Proposed American Heart Association Algorithm for Cardiovascular Screening Before Kidney Transplantation.

Nielsen M, Dahl J, Jespersen B, Ivarsen P, Birn H, Winther S J Am Heart Assoc. 2023; 12(24):e031150.

PMID: 38084711 PMC: 10863782. DOI: 10.1161/JAHA.123.031150.


Coronary Revascularization Versus Optimal Medical Therapy in Renal Transplant Candidates With Coronary Artery Disease: A Systematic Review and Meta-Analysis.

Siddiqui M, Junarta J, Marhefka G J Am Heart Assoc. 2022; 11(4):e023548.

PMID: 35132876 PMC: 9245820. DOI: 10.1161/JAHA.121.023548.


The assessment of coronary artery disease in patients with end-stage renal disease.

Poli F, Gulsin G, McCann G, Burton J, Graham-Brown M Clin Kidney J. 2019; 12(5):721-734.

PMID: 31583096 PMC: 6768295. DOI: 10.1093/ckj/sfz088.


Calcium Ion Channels: Roles in Infection and Sepsis Mechanisms of Calcium Channel Blocker Benefits in Immunocompromised Patients at Risk for Infection.

DElia J, Weinrauch L Int J Mol Sci. 2018; 19(9).

PMID: 30134544 PMC: 6164603. DOI: 10.3390/ijms19092465.